Mottola Frank has disclosed a series of stock transactions in a recent SEC filing, following the merger of Supernus Pharmaceuticals, Inc. with Indivior Pharmaceuticals, Inc. This merger, which took effect on November 2, 2026, has significant implications for both Mottola and the broader pharmaceutical industry.

Supernus Pharmaceuticals, now a wholly-owned subsidiary of Indivior, has undergone a transformation that may reshape competitive dynamics in the pharmaceutical sector. Mottola's transactions reflect the adjustments made as a result of this merger, which has been a strategic move within an increasingly competitive landscape.

Background

Mottola Frank is an officer at Supernus Pharmaceuticals, Inc., a company classified under the pharmaceutical preparations sector. The company, which has recently undergone a name change to Supernus, Inc., is located in Rockville, Maryland. The recent SEC filings indicate a focus on transparency regarding stock ownership and transactions that are crucial for stakeholders.

What the Filing Says

The SEC filing, accession number 0001804567-26-000018, reveals that Mottola disposed of 19,544 shares of Supernus Pharmaceuticals common stock and acquired 100,000 shares of restricted stock units (RSUs) from the merger. Additionally, Mottola received performance share units and employee stock options as part of the transition to Supernus, Inc. The filing states, "the reporting person's shares of Supernus Pharmaceuticals common stock were disposed of, and the shares of Supernus, Inc. common stock received in exchange were acquired, pursuant to the merger."

Impact

These transactions may have implications for other stakeholders in the pharmaceutical industry, particularly competitors of Supernus, Inc. The merger could prompt strategic responses from other companies in the sector as they adapt to the changing market landscape. Mottola's role as Chief Technology Operations Officer positions him as a key player in navigating these changes.

What's Next

The filing does not specify what happens next regarding Mottola's stock transactions or any further actions related to the merger. Stakeholders will be watching closely for additional updates as Supernus, Inc. integrates its operations following the merger.